Sertraline — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

5 Recruiting

2 Completed trials

10 Sponsors

11 Countries

Phase III

Phase II/III

Phase II

Phase IV

Phase III: 4 Phase II/III: 1 Phase II: 1 Phase IV: 4

Indications tested

Anxiety 1 Schizophrenia 1 Psychotic disorder 1 Heart failure with preserved ejection fraction 1 Anxiety disorder 1

Sponsors using this IMP

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz 1 Medical University Of Gdansk 1 Medical University Of Vienna 1 Otsuka Pharmaceutical Development And Commercialization Inc. 1 Parnassia Groep B.V. 1 Region Hovedstaden 1 Region Hovedstadens Psykiatriske 1 Universita Degli Studi Di Verona 1 Universitair Medisch Centrum Utrecht 1 University Medical Center Utrecht 1

All trials

10 total

A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised

2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending

2025-522967-13-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
UNPRESCRIB-D Pending

2026-526314-90-00 Phase IV 1 country Region Hovedstaden
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared… Recruiting

2023-506605-19-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
Selective serotonin reuptake inhibition in patients with advanced gastroesophageal cancer receiving immunochemotherapy: a prospective phase … Recruiting

2024-518631-11-00 Phase II 1 country Medical University Of Vienna
"SAFE DISCONTINUATION OF ANTIDEPRESSANTS IN INDIVIDUALS WITH CLINICALLY REMITTED DEPRESSIVE DISORDERS" Recruiting

2023-509377-23-00 Phase IV 1 country Universita Degli Studi Di Verona
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Phase IV 3 countries Parnassia Groep B.V.
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting

2022-501428-45-00 Phase III 1 country Region Hovedstadens Psykiatriske
The effect of sertraline on anxiety-depressive symptoms, endothelial dysfunction and biomarkers in heart failure patients with preserved eje… Ended

2024-515061-33-00 Phase III 1 country Medical University Of Gdansk
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.

Showing 1–10 of 10 trials

← All drugs A–Z